Latest AI and machine learning research in dyslipidemia for healthcare professionals.
Alzheimer’s disease (AD) is a complex neurodegenerative disorder with limited therapeutic options. The original DeepDrug framework by Li et al. (2025) relied on somatic mutation data and emphasized long genes to guide AD drug repurposing. However, emerging evidence suggests that germline genetic variants play a more central role in AD pathogenesis. In response, we develop DeepDrug2, an enhanced AI...
Prolonged fasting may benefit metabolic health, but data in healthy individuals remain limited. We performed a randomized, waitlist-controlled study (LEANER study), with 38 healthy participants completing a 5-day-fasting intervention with 12-week follow-up. Fasting acutely lowered body mass index (BMI), via fat mass loss. These changes partially persisted at follow-up. Fasting altered the gut micr...
Osteoporosis is characterized by diminished BMD and deteriorated bone microstructure, significantly increasing fracture susceptibility. This study lev...
Alzheimer’s disease (AD), the leading cause of dementia, imposes a significant societal and economic burden; however, its complex molecular mechanisms...
Clinical practice guidelines recommend cardiovascular toxicity risk restratification including evaluation of new cardiovascular risk factors and cardi...
Magnetic Resonance Diffusion-Weighted Imaging (DWI) is a crucial tool for diagnosing acute ischemic stroke, yet some patients present as DWI-negative....
Inadequate pharmacologic stress may limit the diagnostic and prognostic accuracy of myocardial perfusion imaging (MPI). The splenic ratio (SR), a meas...
Cardiovascular risk prediction models, such as PCE, QRISK3, and SCORE2 are recommended tools to guide treatment initiation/intensification in primary ...
Accurate identification of direct causal (parental) variables for a target is of primary interest in many applications, especially in biomedical scien...
Hepatic steatosis (HS) is a common cardiometabolic risk factor frequently present but under-diagnosed in patients with suspected or known coronary art...
Iron overload promotes atherosclerosis in mice and causes vascular dysfunction in humans with Hemochromatosis. However, data are controversial on whet...
Development of anti-drug antibodies (ADAs) is a barrier to long-term efficacy of biologic therapies in rheumatoid arthritis (RA), but no biomarkers ex...
Cardiovascular disease (CVD) remains the foremost contributor to global illness and death, underscoring the critical need for effective tools that can...
OSA and MetS have a bidirectional relationship but increasing evidence suggests metabolic heterogeneity in OSA, systematic phenotyping of metabolic dr...
White adipose tissue dysfunction has emerged as a critical factor in cardiometabolic disease development, yet the cellular microstructure and genetic ...
Atherosclerosis (AS) is a major cause for cardiovascular disease, and mitochondrial permeability transition driven necrosis (MPTDN) is often associate...
The indicator cell assay platform (iCAP) is a novel next-generation approach for blood-based diagnostics that uses standardized cells as biosensors to...
Carotid plaque presence is associated with cardiovascular risk, even among asymptomatic individuals. While deep learning has shown promise for carotid...
Monitoring the effectiveness of statin therapy in patients with dyslipidemia is essential for ensuring optimal treatment outcomes. The current standar...
Hypertension is a major modifiable risk factor for cardiovascular diseases. Early identification of high-risk individuals using predictive models can ...